NEW YORK (
) - Shares of
The Medicines Co.
reached 52-week highs on Wednesday.
Both stocks are rated as buys by
The Medicines Cos.
The pharmaceutical company reported Wednesday fourth-quarter earnings of $19.6 million, or 36 cents a share, down from year-ago earnings of $58.6 million, or $1.09 a share.
Shares of Medicines hit a 52-week high Wednesday of $22.82. The stock's 52-week low of $12.33 was set on Aug. 9.
Medicines has a forward P/E of 18.98; the average for pharmaceutical companies is 21.93. For comparison,
( PRX) both have lower forward P/Es of 12.71 and 10.46.
Five of the seven analysts who cover Medicines rate it at buy. Two analysts have hold ratings.
gives Medicines a B grade and
price target. The stock has risen 19.05% year to date.
The nutritional supplement marketing company Tuesday reported fourth-quarter earnings of $105.4 million, or 86 cents a share, up from year-ago earnings of $86.3 million, or 69 cents a share.
"We reiterate our BUY rating and believe Herbalife's efficient business model along with deployment of its daily consumption models across its major markets will continue to drive double-digit revenue and earnings growth," Canaccord analysts wrote in a report Wednesday.
Share of Herbalife hit a 52-week high Wednesday of $67.40. The stock's 52-week low of $34.23 was set a year ago.
Ten of the 11 analysts who cover the stock rate it at buy; one analyst is at sell.
Herbalife gets an A+ grade from
price target. The stock has increased 28.59% year to date.
Written by Alexandra Zendrian in New York
>To contact the writer of this article, click here:
>To submit a news tip, send an email to:
>To follow the writer on Twitter, go to